Nrx pharmaceuticals, inc. (nasdaq:nrxp) reschedules conference call to discuss third quarter and year to date 2024 financial results to november 18, 2024

Wilmington, del. , nov. 13, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that it will reschedule its third quarter and year to date 2024 results conference call to monday november 18, 2024 at 4:30pm et, to accommodate any additional corporate news.
NRXP Ratings Summary
NRXP Quant Ranking